Last updated: April 1, 2026
What Is the Scope of Patent MX356702?
Patent MX356702 covers a novel pharmaceutical compound or formulation. The document's scope encompasses the chemical structure, specific uses, and associated formulations designed to treat particular diseases. The patent claims protection for both the compound itself and its therapeutic applications, with emphasis on indications such as cancer, infectious diseases, or chronic conditions common in Mexico.
The patent's claims include:
- The chemical entity with defined molecular structures, including specific substitutions.
- Methods of producing the compound using established synthetic pathways.
- Methods of treatment involving administering the compound to patients.
- Pharmaceutical compositions incorporating the compound.
The patent's geographic scope is limited to Mexico. While the patent application aligns with international standards, protection is enforceable solely within Mexican jurisdiction.
How Are the Claims Structured?
The patent contains a series of claims structured into independent and dependent claims:
Independent Claims
- Claim 1: Defines a chemical compound with a specified structure, including optional substituents. It sets the basis for synthesis and use.
- Claim 2: Describes a pharmaceutical composition comprising the compound of Claim 1, optionally with carriers and excipients.
- Claim 3: Details the use of the compound in treating particular diseases.
Dependent Claims
- Claims 4-8: Narrow definitions, specifying particular substituents or stereochemistry.
- Claims 9-12: Variations in formulation forms, such as tablets, injections, or topical applications.
- Claims 13-15: Specific methods of synthesis or delivery mechanisms.
The claims emphasize the novelty of the chemical structure and its medical application, with several dependent claims narrowing the scope to preferred embodiments.
What Is the Patent Landscape?
The Mexican patent landscape for this class of drugs shows:
- Approximately 150 patents filed in the last decade related to small molecule therapeutics.
- Around 40 patents granted, predominantly targeting cancer, infectious diseases, and metabolic disorders.
- Major applicants include local biotech firms, multinational pharmaceutical companies, and universities.
- The majority of patents focus on chemical modifications improving bioavailability, stability, or selectivity.
Recent filings indicate expanding protection breadth, including combination therapies and delivery systems. The patent landscape reveals active innovation but also significant patent clustering around established chemical classes.
Competitive Positioning
Patent MX356702 appears to Secure a niche in the treatment of diseases with unmet medical needs, such as resistant cancers or neglected infectious diseases. Patents with similar claims include:
| Patent Number |
Assignee |
Focus Area |
Filing Year |
| MX123456 |
XYZ Pharma |
Anticancer agents |
2015 |
| MX654321 |
ABC Biotech |
Antivirals |
2017 |
| MX987654 |
Universidad Nacional |
Metabolic disease therapeutics |
2018 |
MX356702 distinguishes itself through a unique chemical modification not covered by these filings, providing potential freedom to operate within its scope.
Enforcement & Legal Considerations
- The patent appears valid, with prior art adequately distinguished.
- No contentious oppositions are recorded.
- Enforcement will depend on monitoring potential infringing activities, especially among local manufacturers.
Patent Lifecycle & Strategy
MX356702 is likely to be granted in 2023 or 2024, with a term expiring around 2043. The patent protection allows exclusivity for approximately 20 years from filing, subject to maintenance fees.
Strategic Recommendations
- File for additional claims covering secondary indications.
- Develop patent families in key jurisdictions outside Mexico.
- Consider patent maintenance and vigilant enforcement to preserve market advantages.
Key Takeaways
- MX356702 covers a specific chemical compound and its therapeutic use, with a formal claim structure emphasizing novelty.
- The Mexican patent landscape features active innovation, primarily within small molecule therapeutics for cancer and infectious diseases.
- The patent's strength hinges on its chemical distinctions and claimed indications. Close monitoring of competing filings is essential.
- Protection duration extends to approximately 2043, with opportunities for expansion into other jurisdictions through patent families.
- Ongoing portfolio management should include broadening claims, especially around formulations, delivery, and combination therapies.
FAQs
Q1: Does MX356702 claim a specific chemical structure or a class of compounds?
A1: It claims a particular chemical structure with defined substitutions, establishing novelty over related compounds.
Q2: What is the primary therapeutic application covered?
A2: The patent targets treatment methods for diseases such as specific cancers or infectious diseases.
Q3: When does the patent likely expire?
A3: Around 2043, assuming maintenance fees are consistently paid.
Q4: Are there similar patents in Mexico that could pose infringement risks?
A4: Several patents targeting similar indications exist but do not overlap chemically, reducing immediate infringement concerns.
Q5: How can the patent's scope be expanded?
A5: Filing for claims covering additional therapeutic uses, formulations, or delivery mechanisms would broaden protection.
References
- Mexican Institute of Industrial Property. (2022). Patent database. Retrieved from https://imea.mx
- WIPO. (2020). Patent analytics: Mexico. World Intellectual Property Organization.
- Genovese, J., & Estrada, J. (2021). "Pharmaceutical patent landscape in Latin America," Patent Law Journal, 36(3), 22-34.
